Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 17, 2026 | Regence BCBS | Chemical PeelsPayerPolicy · REGENCE-SUR12.50 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Charged-Particle (Proton) RadiotherapyPayerPolicy · REGENCE-MED49 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cell Therapy for Peripheral Arterial DiseasePayerPolicy · REGENCE-MED141 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Cardiac Hemodynamic and Thoracic Fluid Index Monitoring for the Management of Heart Failure in the Outpatient SettingPayerPolicy · REGENCE-MED33 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Bronchial ValvesPayerPolicy · REGENCE-SUR184 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Bronchial ThermoplastyPayerPolicy · REGENCE-SUR178 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | BRAF Genetic Testing To Select Melanoma or Glioma Patients for Targeted TherapyPayerPolicy · REGENCE-GT41 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone TurnoverPayerPolicy · REGENCE-LAB23 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Blepharoplasty, Repair of Blepharoptosis, and Brow Ptosis RepairPayerPolicy · REGENCE-SUR12.05 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Biomarkers for Cardiovascular DiseasePayerPolicy · REGENCE-LAB78 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Bioimpedance Devices for Detection and Management of LymphedemaPayerPolicy · REGENCE-DME82 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | BiofeedbackPayerPolicy · REGENCE-AH32 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Bioengineered Skin and Soft Tissue Substitutes and Amniotic ProductsPayerPolicy · REGENCE-MED170 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Biochemical and Cellular Markers of Alzheimer's DiseasePayerPolicy · REGENCE-LAB22 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Benign Prostatic Hyperplasia Surgical TreatmentsPayerPolicy · REGENCE-SUR210 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Baroreflex Stimulation DevicesPayerPolicy · REGENCE-SUR183 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Bariatric SurgeryPayerPolicy · REGENCE-SUR58 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Balloon Ostial Dilation for Treatment of SinusitisPayerPolicy · REGENCE-SUR153 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Balloon Dilation of the Eustachian TubePayerPolicy · REGENCE-SUR206 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Automated Point-of-Care Nerve Conduction StudiesPayerPolicy · REGENCE-MED128 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Automated Percutaneous and Percutaneous Endoscopic DiscectomyPayerPolicy · REGENCE-SUR145 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Autologous Chondrocyte Implantation for Focal Articular Cartilage LesionsPayerPolicy · REGENCE-SUR87 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Autologous Blood-Derived Growth Factors as a Treatment for Wound Healing and Other Miscellaneous ConditionsPayerPolicy · REGENCE-MED77 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Auricular ElectrostimulationPayerPolicy · REGENCE-MED146 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Augmentative Communication Devices and SystemsPayerPolicy · REGENCE-DME52 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Assays of Genetic Expression in Tumore Tissue as a Technique to Determine Breast Cancer PrognosisPayerPolicy · REGENCE-GT42 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Artificial Intervertebral DiscPayerPolicy · REGENCE-SUR127 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Artificial Intelligence Augmented Analysis of Atherosclerotic Plaque from Computed Tomography ScanPayerPolicy · REGENCE-RAD61 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Applied Behavior Analysis Initial Assessment for the Treatment of Autism Spectrum DisordersPayerPolicy · REGENCE-BH33 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Applied Behavior Analysis for the Treatment of Autism Spectrum DisordersPayerPolicy · REGENCE-BH18 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Apolipoprotein E for Risk Assessment and Management of Cardiovascular DiseasePayerPolicy · REGENCE-GT05 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Anterior Abdominal Wall (Including Incisional) Hernia RepairPayerPolicy · REGENCE-SUR12.03 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Annular Closure DevicesPayerPolicy · REGENCE-SUR243 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Analysis of Proteomic and Metabolomic Patterns for Cancer Detection, Risk, Prognosis, or Treatment SelectionPayerPolicy · REGENCE-LAB41 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Analysis of Human DNA or RNA in Stool Samples as a Technique for Colorectal Cancer ScreeningPayerPolicy · REGENCE-GT12 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF-EMF) for Cancer TreatmentPayerPolicy · REGENCE-DME96 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes and Myeloproliferative NeoplasmsPayerPolicy · REGENCE-TRA45.24 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Allogeneic Hematopoietic Cell Transplantation for Genetic Diseases and Acquired AnemiasPayerPolicy · REGENCE-TRA45.25 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Allergy and Sensitivity Tests of Uncertain EfficacyPayerPolicy · REGENCE-LAB01 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Air Ambulance TransportPayerPolicy · REGENCE-UM13 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Administrative Guidelines to Determine Dental vs Medical ServicesPayerPolicy · REGENCE-AH35 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Adipose-derived Stem Cell Enrichment in Autologous Fat Grafting to the BreastPayerPolicy · REGENCE-SUR182 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | ActigraphyPayerPolicy · REGENCE-MED125 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Ablation of Primary and Metastatic Liver TumorsPayerPolicy · REGENCE-SUR204 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Ablation of Peripheral Nerves to Treat PainPayerPolicy · REGENCE-SUR236 | Criteria changed |
|---|
| May 17, 2026 | Regence BCBS | Ablation for the Treatment of Chronic RhinitisPayerPolicy · REGENCE-SUR224 | Criteria changed |
|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Zoledronic Acid (Zometa)PayerPolicy · BCBSTN-dd1a89ad07 | Criteria changed |
|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Zoledronic Acid (Reclast)PayerPolicy · BCBSTN-644f7a37c5 | Criteria changed |
|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Zanidatamab-hrii (Ziihera)PayerPolicy · BCBSTN-f76069c1b8 | Criteria changed |
|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Ziv-Aflibercept (Zaltrap)PayerPolicy · BCBSTN-66ef690ba3 | Criteria changed |
|---|